Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing

Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing

10.2174/0929867311320100001

Saved in:
Bibliographic Details
Main Authors: Ho, H.K., Németh, G., Ng, Y.R., Pang, E., Szántai-Kis, C., Zsákai, L., Breza, N., Greff, Z., Horváth, Z., Pató, J., Szabadkai, I., Szokol, B., Baska, F., Orfi, L., Ullrich, A., Kéri, G., Chua, B.T.
Other Authors: PHARMACY
Format: Article
Published: 2014
Subjects:
FGFR4
Inhibitor
Phosphorylation
Tyrosine Kinase
Online Access:http://scholarbank.nus.edu.sg/handle/10635/105815
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

http://scholarbank.nus.edu.sg/handle/10635/105815

Similar Items